Abstract
The study of protein-drug interaction is of pivotal importance to understand the structural features essential for ligand affinity. The explosion of information about protein structures has paved the way to develop structure-based virtual screening approaches. Parasitic protein kinases have been pointed out as potential targets for antiparasitic development. The identification of protein kinases in the Plasmodium falciparum genome has opened the possibility to test new families of inhibitors as potential antimalarial drugs. In addition, other key enzymes which play roles in biosynthetic pathways, such as enoyl reductase and chorismate synthase, can be valuable targets for drug development. This review is focused on these protein targets that may help to materialize new generations of antimalarial drugs.
Keywords: Plasmodium falciparum, antimalarial drugs, structure-based virtual screening, protein kinases, enoyl reductase, chorismate synthase
Current Drug Targets
Title: Protein-Drug Interaction Studies for Development of Drugs Against Plasmodium falciparum
Volume: 10 Issue: 3
Author(s): Walter Filgueira de Azevedo Jr., Rafael Andrade Caceres, Ivani Pauli, Luis Fernando S.M. Timmers, Guy Barros Barcellos, Kelen Beiestorf Rocha and Milena Botelho Pereira Soares
Affiliation:
Keywords: Plasmodium falciparum, antimalarial drugs, structure-based virtual screening, protein kinases, enoyl reductase, chorismate synthase
Abstract: The study of protein-drug interaction is of pivotal importance to understand the structural features essential for ligand affinity. The explosion of information about protein structures has paved the way to develop structure-based virtual screening approaches. Parasitic protein kinases have been pointed out as potential targets for antiparasitic development. The identification of protein kinases in the Plasmodium falciparum genome has opened the possibility to test new families of inhibitors as potential antimalarial drugs. In addition, other key enzymes which play roles in biosynthetic pathways, such as enoyl reductase and chorismate synthase, can be valuable targets for drug development. This review is focused on these protein targets that may help to materialize new generations of antimalarial drugs.
Export Options
About this article
Cite this article as:
de Azevedo Jr. Filgueira Walter, Caceres Andrade Rafael, Pauli Ivani, Timmers S.M. Luis Fernando, Barcellos Barros Guy, Rocha Beiestorf Kelen and Soares Botelho Pereira Milena, Protein-Drug Interaction Studies for Development of Drugs Against Plasmodium falciparum, Current Drug Targets 2009; 10 (3) . https://dx.doi.org/10.2174/138945009787581104
DOI https://dx.doi.org/10.2174/138945009787581104 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
In Search of Drug Targets for Mycobacterium tuberculosis
Infectious Disorders - Drug Targets Structure-Activity Design, Synthesis and Biological Activity of Newer Imidazole- Triazine Clubbed Derivatives as Antimicrobial and Antitubercular Agents
Letters in Organic Chemistry Targeted Drug Delivery Systems for Lung Macrophages
Current Drug Targets Personalized Drug Discovery: HCA Approach Optimized for Rare Diseases at Tel Aviv University
Combinatorial Chemistry & High Throughput Screening Lyn Regulates Cytotoxicity in Respiratory Epithelial Cells Challenged by Cigarette Smoke Extracts
Current Molecular Medicine New Oral Anticoagulants for the Management of Heparin Induced Thrombocytopenia: A Focused Literature Review
Cardiovascular & Hematological Agents in Medicinal Chemistry Recent Patents Regarding Essential Oils and the Significance of their Constituents in Human Health and Treatment
Recent Patents on Anti-Infective Drug Discovery Globalization of Clinical Trials – Where are We Heading?
Current Clinical Pharmacology Structure-Based Approaches to the Development of Novel Anti-Malarials
Current Drug Targets Targeting Bacterial Metalloenzymes: A New Strategy for the Development of Anti-Infective Agents
Anti-Infective Agents in Medicinal Chemistry Current and Future Pharmaceutical Therapy for Rheumatoid Arthritis
Current Pharmaceutical Design HIV-Infected Patients and Liver Transplantation: Who, When and Why
Current HIV Research Is Human Immunodeficiency Virus-Mediated Dementia an Autophagic Defect that Leads to Neurodegeneration?
CNS & Neurological Disorders - Drug Targets Diagnosis and Treatment of Multidrug-Resistant Tuberculosis in Developed and Developing Countries: Finally Towards Equality?
Current Respiratory Medicine Reviews Electroporation Advances in Large Animals
Current Gene Therapy Chemoinfectomics in Drug Design and Development
Anti-Infective Agents Maternal Vitamin D Status and Development of Asthma and Allergy in Early Childhood
Mini-Reviews in Medicinal Chemistry Novel Delivery Systems for Anti-Allergic Agents: Allergic Disease and Innovative Treatments
Current Drug Delivery Targeting Tumor Necrosis Factor-α in the Therapy of Psoriasis
Current Drug Targets - Inflammation & Allergy Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery
Current Drug Research Reviews